aap Implantate AG Stock price Xetra

Equities

AAQ

DE0005066609

Medical Equipment, Supplies & Distribution

End-of-day quote Xetra 06:00:00 2024-02-04 pm EST 5-day change 1st Jan Change
0.73 EUR -2.67% Intraday chart for aap Implantate AG -9.32% -12.05%
Sales 2023 * 11.3M 12.21M Sales 2024 * 13M 14.05M Capitalization 7.54M 8.15M
Net income 2023 * -3M -3.24M Net income 2024 * -1M -1.08M EV / Sales 2023 * 1.1 x
Net Debt 2023 * 4.9M 5.3M Net Debt 2024 * 7M 7.57M EV / Sales 2024 * 1.12 x
P/E ratio 2023 *
-1.74 x
P/E ratio 2024 *
-3.83 x
Employees -
Yield 2023 *
-
Yield 2024 *
-
Free-Float 48.7%
More Fundamentals * Assessed data
Dynamic Chart
Aap Implantate AG Announces Sales Results for the Second Quarter and Half Year Ended 30 June 2021 CI
Aap Implantate Ag Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Aap Implantate AG Provides Earnings Guidance for the Year 2021 CI
Aap Implantate AG Announces Sales Results for the First Quarter of 2021 CI
Aap Implantate AG Provides Sales Guidance for the Second Quarter of 2021 CI
Aap Implantate AG Announces Sales Results for the Fourth Quarter and Full Year Ended December 31, 2020 CI
Aap Implantate AG Provides Earnings Guidance for the Fiscal Year 2021 CI
Aap Implantate AG Appoints Agnieszka Mierzejewska as COO with Effect from 1 January 2021 CI
Aap Implantate AG Provides Earnings Guidance for the Year 2020 CI
Aap Implantate AG Announces Sales Results for the Third Quarter and Nine Months Ended September 30, 2020 CI
Aap Implantate AG Provides Earnings Guidance for the Full Year of Fiscal 2020 CI
Aap Implantate AG Provides Earnings Guidance for 2020 CI
Aap Receives Approval from Ethics Commissions for Human Clinical Study for Innovative Antibacterial Silver Coating Technology; All Regulatory Requirements for Starting Study in Germany Fulfilled CI
Aap Implantate AG Announces Sales Results for the Fourth Quarter and Full Year Ended December 31, 2019 CI
Aap Implantate AG Receives Further Funding of Up to Eur 2.7 Million for Its Innovative Antibacterial Silver Coating Technology CI
More news
aap Implantate AG is a Germany-based provider of medical devices for human muscular and skeletal systems. The Company focuses on trauma and biomaterials products for orthopedics. The Biomaterials portfolio comprises bone substitutes for the filling of aseptic bone defects, bone cements and accessories for the application in arthroplasty, bone cements and accessories for the application in vertebroplasty and kyphoplasty. The trauma portfolio includes a wide range of cannulated screws, standard plates and screws for miniature, small and large bone fragments, among others . It also develops LOQTEQ, a technology that allows for fracture compression with subsequent locking fixation in one surgical step. The Company operates a network of distributors in more than 60 countries, and cooperates directly with physicians and hospital customers.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.765 EUR
Average target price
0.8 EUR
Spread / Average Target
+4.58%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock aap Implantate AG
  4. Stock aap Implantate AG - Xetra